Insights+: EMA Marketing Authorization of New Drugs in June 2024
Shots: The EMA granted Positive Opinion to 4 Biologics and 3 New...
Shots: The EMA granted Positive Opinion to 4 Biologics and 3 New...
Shots: Small cell lung cancer (SCLC) aka Oat cell carcinoma is a rare &...
Shots: Backed with an evergreen investment strategy, Invus makes investmen...
Shots: PharmaShots has compiled a list of US FDA-approved drugs...
Shots: Biosimilars are developed to be highly similar versions o...
Shots: The second quarter of 2024 highlights major acquisitions in the pharma and...
Incisive News in 3 Shots.